ArticleTherapeutic advances in medical oncology2026
HAIC combined with lenvatinib and tislelizumab for HCC with concurrent PVTT and pulmonary metastasis: a multicenter propensity score matching analysis.
Song Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.